<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Genscript-Probio on Bioecon</title><link>https://en.bioecon.ru/companies/genscript-probio/</link><description>Recent content in Genscript-Probio on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 01 Jul 2026 16:20:16 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/genscript-probio/index.xml" rel="self" type="application/rss+xml"/><item><title>Probiotics and postbiotics for companion animals</title><link>https://en.bioecon.ru/technology/probiotics-postbiotics-animals/</link><pubDate>Wed, 01 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/probiotics-postbiotics-animals/</guid><description>Species-specific probiotics and heat-stable postbiotics for dog and cat gut health — a $3.2B market driven by pet humanisation, growing at 11% CAGR.</description></item><item><title>Bioproduction CDMO/CMO (biologics/ATMP/mRNA)</title><link>https://en.bioecon.ru/technology/bioproduction-cdmo-cmo/</link><pubDate>Sun, 28 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/bioproduction-cdmo-cmo/</guid><description>Contract development and manufacturing organizations providing specialized infrastructure for advanced biopharmaceuticals.</description></item></channel></rss>